#DEA News | MunchMakers

Rep. Beth Van Duyne is circulating legislation to exempt hemp THC beverages from the DEA's upcoming ban on intoxicating hemp products, creat...

KFF debuts policy tracker monitoring Trump administration actions on cannabis rescheduling and substance use reform, providing transparency ...

Cannabis Industry Victims Educating Litigators filed an appeal challenging the DEA's marijuana rescheduling proposal, arguing the process re...

Hemp companies have filed federal lawsuits over the DEA's December rule classifying HHC as a Schedule I substance, arguing the synthetic can...

President Trump faces a federal lawsuit challenging marijuana rescheduling, filed by doctors, addiction specialists, and a pharma company cl...

Louisiana AG Liz Murrill has withdrawn from a lawsuit challenging the DEA's decision to reschedule cannabis to Schedule III, leaving Indiana...

Cannabis attorney Bob Hoban warns that DEA registration forms—not flying with weed—create the real self-incrimination risk, as operators mus...

Medx Holdings filed for DEA registration through its Lazydaze ABQ subsidiary, joining a select group of public companies seeking federal app...

Advocacy groups from both sides of the marijuana debate have filed notices to testify at DEA's February hearing on rescheduling cannabis to ...

DEA rescheduling would end IRS 280E tax penalties that forced cannabis companies into 70%+ effective tax rates, potentially unlocking $3B+ i...

Former Coast Guard officer Lukas Gilkey built one of Texas' largest hemp companies after leaving drug interdiction. Now federal agencies thr...

Medical cannabis operators are rushing to register with the DEA following marijuana rescheduling, hoping to secure 280E tax relief despite u...

#DEA